Elucidating the precise pharmacological mechanism of motion (MOA) of naturally taking place compounds can be difficult. While Tarselli et al. (60) developed the 1st de novo synthetic pathway to conolidine and showcased this naturally happening compound effectively suppresses responses to both of those chemically induced and inflammation-derived pai… Read More